PharmaJet's Needle-free Delivery System Shows Promise for African Immunization Programs
核心洞察
PharmaJet's Tropis (搜索) needle-free delivery system has demonstrated significant benefits in routine immunization programs across multiple African countries, including Nigeria, Somalia, and Pakistan.
The company will showcase its innovative needle-free intradermal delivery technology at the upcoming Ethiopian Medical Association (搜索)'s 61st Annual Medical Conference in February 2025.
Clinical evidence from multiple countries supports the effectiveness of PharmaJet's technology, particularly in mass vaccination campaigns and routine immunization programs.
PharmaJet is set to demonstrate the advantages of its innovative needle-free delivery technology at the Ethiopian Medical Association (搜索)'s upcoming medical conference, building on successful implementations across multiple African nations.
The company's Tropis (搜索)® System, which has received both CE Mark and WHO PQS certification for intradermal injections, has shown remarkable success in various immunization programs. Paul LaBarre, Vice President of Global Business Development at PharmaJet, emphasized the technology's impact: "The Nigeria study results demonstrate how using Tropis for routine immunization programs can provide significant benefits at all levels of the healthcare system."
Clinical Evidence and Implementation Success
Recent evidence from multiple countries has validated the effectiveness of PharmaJet's needle-free delivery system. In Pakistan, research has shown positive acceptance among caregivers and vaccinators for mass administration of fractional dose inactivated poliovirus (搜索) vaccine (fIPV). Similar successful implementations have been documented in Somalia and Nigeria, particularly in house-to-house vaccination campaigns.
Technology and Regulatory Status
PharmaJet's portfolio includes two key systems:
- The Stratis® System, which has secured U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification for intramuscular or subcutaneous delivery
- The Tropis® System, specifically designed for intradermal injections, holding CE Mark and WHO PQS certification
Upcoming Conference Showcase
The technology will be featured at the Ethiopian Medical Association (搜索)'s 61st Annual Medical Conference and International Health Exhibition, scheduled for February 21-22, 2025, in Addis Ababa. The conference is expected to attract over 3,000 international and local healthcare professionals, providing a platform for showcasing advanced medical technologies and facilitating knowledge exchange among healthcare practitioners.
The company is actively pursuing partnerships with the Ethiopian Ministry of Health and other African healthcare organizations to expand the implementation of their needle-free delivery systems in regional immunization programs.